| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.04B | +19.2% |
| Cost of Revenue | $764.0M | +6.1% |
| Gross Profit | $2.28B | +24.4% |
| R&D Expense | $2.31B | +346.3% |
| SG&A Expense | $803.0M | +136.9% |
| Operating Income | -$2.14B | -3554.8% |
| Pre-tax Income | -$2.06B | -3002.8% |
| Income Tax | -$439.0M | -23.0% |
| Net Income | -$1.62B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.14B | +42.0% |
| Short-term Investments | $49.0M | -76.6% |
| Accounts Receivable | $853.0M | +1.3% |
| Current Assets | $3.31B | +20.6% |
| Total Assets | $4.73B | +28.8% |
| Current Liabilities | $733.0M | -7.8% |
| Total Liabilities | $800.0M | -12.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $586.0M | +111.6% |
| Capital Expenditures | $54.0M | +125.0% |
| Investing Cash Flow | $135.0M | +15.4% |
| Financing Cash Flow | -$30.0M | -165.2% |
| Free Cash Flow | $532.0M | +110.3% |
| -479.0% |
| EPS (Basic) | -$12.43 | -1250.9% |
| EPS (Diluted) | -$12.43 | -1394.8% |
| Stockholders' Equity |
| $3.75B |
| +5959.4% |